Colorectal Carcinoma Metastases in Liver: Laser-induced Interstitial Thermotherapy—Local Tumor Control Rate and Survival Data
- 1 February 2004
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 230 (2), 450-458
- https://doi.org/10.1148/radiol.2302020646
Abstract
PURPOSE: To evaluate the local tumor control and survival data for magnetic resonance (MR) imaging–guided laser-induced interstitial thermotherapy (LITT) of colorectal liver metastases. MATERIALS AND METHODS: MR imaging–guided LITT was performed in 603 patients (mean age, 61.2 years) with 1,801 liver metastases of colorectal cancer. Survival rates were calculated by means of the Kaplan-Meier method. Local tumor control and tumor volume were evaluated with nonenhanced and contrast material–enhanced MR imaging. Indications for the procedure were defined for patients with five or fewer metastases, none of which were larger than 5 cm in diameter. The indications included recurrent liver metastases after partial liver resection in 37.6% of study patients, metastases in both liver lobes in 32.5%, locally nonresectable lesions in 11.3%, general contraindications for surgery in 4.6%, and refusal to undergo surgical resection in 13.9%. RESULTS: Local recurrence rate at 6-month follow-up was 1.9% (nine of 474) for metastases up to 2 cm in diameter, 2.4% (13 of 539) for metastases 2.1–3.0 cm in diameter, 1.2% (four of 327) for metastases 3.1–4.0 cm in diameter, and 4.4% (13 of 294) for metastases larger than 4 cm in diameter. The mean survival rate for all treated patients, with calculation started on the date of diagnosis of the metastases (which were treated with LITT) was 4.4 years (95% CI: 4.0, 4.8) (1-year survival, 94%; 2-year survival, 77%; 3-year survival, 56%; 5-year survival, 37%). Median survival was 3.5 years (95% CI: 3.0, 3.9). Mean survival after the first LITT treatment was 3.8 years (95% CI: 3.4, 4.2). Median survival was 2.9 years (95% CI: 2.4, 3.3). CONCLUSION: MR imaging–guided LITT yields high local tumor control and survival rates in well-selected patients with limited liver metastases of colorectal carcinoma. © RSNA, 2003Keywords
This publication has 50 references indexed in Scilit:
- In situ ablation of experimental liver metastases delays and reduces residual intrahepatic tumour growth and peritoneal tumour spread compared with hepatic resectionBritish Journal of Surgery, 2002
- Radiofrequency thermal ablation of hepatocellular carcinomaEuropean Journal of Ultrasound, 2001
- Hepatectomy for liver metastases from breast cancerEuropean Journal of Surgical Oncology, 1995
- The effect of partial hepatectomy on tumor growth in rats:In vivo andin vitro studiesHepatology, 1995
- Hepatocellular Carcinoma: Update on Diagnosis and TreatmentDigestive Diseases, 1995
- Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor αBritish Journal of Surgery, 1995
- Factors influencing the natural history of colorectal liver metastasesThe Lancet, 1994
- Repeat liver resection for recurrent colorectal metastasesBritish Journal of Surgery, 1993
- One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinantsBritish Journal of Surgery, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958